Literature DB >> 19273630

Racial differences in primary central nervous system lymphoma incidence and survival rates.

Jose S Pulido1, Robert A Vierkant, Janet E Olson, Lauren Abrey, David Schiff, Brian Patrick O'Neill.   

Abstract

To determine racial and ethnic differences in incidence and survival in patients with primary central nervous system lymphoma (PCNSL), NCI Surveillance, Epidemiology, and End Results (SEER) program data from 1992 to 2002 were queried. Data were substratified by age (20-49 years vs. 50 or above) and race (White, Black, Asian/Pacific Islander [A/PI], American Indian/Alaskan Native [AI/AN]). Incidence of PCNSL and survival were calculated by SEER(*)Stat software. The incidence rates were 0.94 per 100,000 per year (95% confidence interval [CI] 0.90-0.98) for Whites, 1.10 (95% CI 0.98-1.22) for Blacks, 0.51 (95% CI 0.28-0.74) for AI/AN, and 0.64 (95% CI 0.56-0.72) for A/PI. In patients aged 20-49 years the rates were 0.72 (95% CI 0.68-0.76) for Whites, 1.43 (95% CI 1.27-1.59) for Blacks, 0.58 (95% CI 0.30-0.86) for AI/AN, and 0.21 (CI 0.15-0.27) for A/PI. In patients over 49 years, the rates were 1.30 (95% CI 1.22-1.38) for Whites, 0.56 (95% CI 0.40-0.72) for Blacks, 0.34 (95% CI 0-0.70) for AI/AN, and 1.31 (95% CI 1.00-1.53) for A/PI. PCNSL incidence for ages 20-49 years for Black patients was twice that for Whites. Incidence for ages over 49 years for Whites was twice that for Blacks. Survival at 12 months, 24 months, and 60 months was higher among Whites than Blacks. Research is needed to determine the origin of these differences.

Entities:  

Mesh:

Year:  2009        PMID: 19273630      PMCID: PMC2718976          DOI: 10.1215/15228517-2008-103

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  17 in total

1.  Prevalence of HIV infection among young adults in the United States: results from the Add Health study.

Authors:  Martina Morris; Mark S Handcock; William C Miller; Carol A Ford; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen M Harris; J Richard Udry
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

2.  Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229.

Authors:  M R Modiano; P Villar-Werstler; J Crowley; S E Salmon
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

3.  The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma.

Authors:  Rony M Abou-Jawde; Rachid Baz; Esteban Walker; Toni K Choueiri; Mary Ann Karam; Janice Reed; Beth Faiman; Mohamad Hussein
Journal:  Haematologica       Date:  2006-09-07       Impact factor: 9.941

4.  Deaths: leading causes for 2002.

Authors:  Robert N Anderson; Betty L Smith
Journal:  Natl Vital Stat Rep       Date:  2005-03-07

5.  A longitudinal study of the prevalence, development, and persistence of HIV/sexually transmitted infection risk behaviors in delinquent youth: implications for health care in the community.

Authors:  Erin Gregory Romero; Linda A Teplin; Gary M McClelland; Karen M Abram; Leah J Welty; Jason J Washburn
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

6.  Increasing incidence of primary brain lymphoma in the US.

Authors:  N L Eby; S Grufferman; C M Flannelly; S C Schold; F S Vogel; P C Burger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

7.  Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.

Authors:  P H Levine; S C Steinhorn; L G Ries; J L Aron
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

8.  Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002.

Authors:  Jennifer F Yamamoto; Marc T Goodman
Journal:  Cancer Causes Control       Date:  2007-12-07       Impact factor: 2.506

Review 9.  Epidemiology of Hodgkin's disease: a review.

Authors:  R A Cartwright; Gillian Watkins
Journal:  Hematol Oncol       Date:  2004-03       Impact factor: 5.271

Review 10.  Origins of socio-economic inequalities in cancer survival: a review.

Authors:  L M Woods; B Rachet; M P Coleman
Journal:  Ann Oncol       Date:  2005-09-02       Impact factor: 32.976

View more
  9 in total

1.  IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas.

Authors:  Hema L Ramkumar; De Fen Shen; Jingsheng Tuo; Rita M Braziel; Sarah E Coupland; Justine R Smith; Chi-Chao Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-25       Impact factor: 3.117

2.  Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.

Authors:  Thomas S Uldrick; Sharon Pipkin; Susan Scheer; Nancy A Hessol
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

3.  Survival among patients with primary central nervous system lymphoma, 1973-2004.

Authors:  Andrew D Norden; Jan Drappatz; Patrick Y Wen; Elizabeth B Claus
Journal:  J Neurooncol       Date:  2010-06-17       Impact factor: 4.130

Review 4.  Central Nervous System Lymphoma: Novel Therapies.

Authors:  Shannon P Fortin Ensign; Diamone Gathers; Julia Erin Wiedmeier; Maciej M Mrugala
Journal:  Curr Treat Options Oncol       Date:  2022-02-19

5.  Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.

Authors:  Parag Mahale; Meredith S Shiels; Charles F Lynch; Eric A Engels
Journal:  Am J Transplant       Date:  2017-09-02       Impact factor: 9.369

6.  Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.

Authors:  J L Villano; M Koshy; H Shaikh; T A Dolecek; B J McCarthy
Journal:  Br J Cancer       Date:  2011-09-13       Impact factor: 7.640

7.  Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis.

Authors:  Inka Puhakka; Hanne Kuitunen; Pekka Jäkälä; Eila Sonkajärvi; Taina Turpeenniemi-Hujanen; Aino Rönkä; Tuomas Selander; Miika Korhonen; Outi Kuittinen
Journal:  BMC Cancer       Date:  2022-03-03       Impact factor: 4.430

8.  Primary intracranial lymphomas.

Authors:  Shagufta T Mufti; Saleh S Baeesa; Jaudah A Al-Maghrabi
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep

9.  Prognostic Factors and Survival in Primary Central Nervous System Lymphoma: A Population-Based Study.

Authors:  Yudong Shan; Yilan Hu
Journal:  Dis Markers       Date:  2018-06-28       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.